2011
DOI: 10.1007/s11434-010-4311-0
|View full text |Cite
|
Sign up to set email alerts
|

The role of human ADA2a in the regulation of p53 acetylation and stability

Abstract: The tumor suppressor protein p53 is a well-known transcription factor that functions as a critical component of the genotoxic stress response via regulating the expression of effector proteins that control cellular fate following DNA damage. The human p300/CBP-associated factor (PCAF)-containing histone acetyltransferase (HAT) complex is important for the stability and activity of p53 via its acetylation. The human homolog of yeast alteration/deficiency in activation 2a (ADA2a) is a stable component of the hum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…TADA2a has been studied as a key component of the PCAF and Ada two-A-containing (ATAC) HAT complexes [30] contributing to histone and non-histone acetylation. For example, TADA2a interacts with p53 to promote the acetylation of p53 at lysine 320, increasing its stability and activity [17,31]. TADA2a may also impact acetylation in a variety of ways during DNA damage-induced apoptosis and cell-cycle arrest [17].…”
Section: Discussionmentioning
confidence: 99%
“…TADA2a has been studied as a key component of the PCAF and Ada two-A-containing (ATAC) HAT complexes [30] contributing to histone and non-histone acetylation. For example, TADA2a interacts with p53 to promote the acetylation of p53 at lysine 320, increasing its stability and activity [17,31]. TADA2a may also impact acetylation in a variety of ways during DNA damage-induced apoptosis and cell-cycle arrest [17].…”
Section: Discussionmentioning
confidence: 99%
“…The pcDB-CCDC134-myc/his and hADA2a-GFP plasmids had been described previously (Huang et al 2011). CCDC134 siRNA and control siRNA were synthesized by GeneChem Corporation (Shanghai, China), and the sequences of the various siRNA had been reported previously (Huang et al 2008).…”
Section: Plasmids Sirna and Antibodiesmentioning
confidence: 99%